EMILY RICHARDS: Open Payments
NPI 1548871403 · VESTAL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$940 in 40 payments from 20 companies in 2025. Trend: 2023 $282 · 2024 $453 · 2025 $940
Food & beverage: $940
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. | 6 | $146 |
| SK Life Science, Inc. | 5 | $142 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $99 |
| Amgen Inc. | 2 | $57 |
| Vanda Pharmaceuticals Inc. | 2 | $56 |
| UCB, Inc. | 2 | $53 |
| GENZYME CORPORATION | 2 | $52 |
| Azurity Pharmaceuticals, Inc. | 2 | $43 |
| Lilly USA, LLC | 2 | $38 |
| LivaNova USA, Inc. | 2 | $33 |
Products named: HYQVIA, UPLIZNA, PONVORY, Rystiggo, ZONISADE, VNS THERAPY SENTIVA MODEL 1000 GENERATOR, BOTOX, FIRDAPSE.
Industry payments across NY — which companies pay providers there.
